Action Titan Pharmaceuticals (TTNP)
Société cotée en bourse. Voici le cours, un aperçu de l'activité et l'essentiel à savoir sur Titan Pharmaceuticals en septembre 2026.
Titan Pharmaceuticals, Inc. is a pharmaceutical company. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus, and Nalmefene Implant, which is for the prevention of relapse in OUD patients following detoxification from opioids Its product development programs are in non-clinical stages of development.
≈
